Medicina
Département
Hospital La Inmaculada
Almería, EspañaPublications en collaboration avec des chercheurs de Hospital La Inmaculada (2)
2012
2004
-
Docetaxel plus epirubicin is a highly active, well-tolerated, first-line chemotherapy for metastatic breast cancer: Results of a large, multicentre phase II study
Cancer Chemotherapy and Pharmacology, Vol. 53, Núm. 1, pp. 75-81